Your session is about to expire
← Back to Search
N Acetylcysteine for Cognitive Impairment
Phase 2
Waitlist Available
Led By Krista L Lanctôt, PhD
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
Study Summary
This trial will test whether NAC can help improve cognitive function in patients with vascular cognitive impairment who are undergoing cardiac rehabilitation.
Eligible Conditions
- Vascular Cognitive Impairment
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in executive function
Secondary outcome measures
Change in memory
Change in processing speed
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: N-acetylcysteineActive Control1 Intervention
Participants randomized into the N-acetylcysteine arm will be receiving N-acetylcysteine for 24 weeks.
Group II: PlaceboPlacebo Group1 Intervention
Participants randomized into the placebo arm will be receiving placebo for 24 weeks.
Find a Location
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
656 Previous Clinical Trials
1,551,382 Total Patients Enrolled
2 Trials studying Vascular Cognitive Impairment
425 Patients Enrolled for Vascular Cognitive Impairment
Krista L Lanctôt, PhDPrincipal InvestigatorSunnybrook Research Institute
2 Previous Clinical Trials
25,015 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have had a stroke in the past.You have extremely high or low blood pressure, as determined by a doctor.You have a current neurological condition such as Parkinson's disease, multiple sclerosis, or significant traumatic brain injury.You have severe liver, kidney, or lung problems, or have been diagnosed with HIV, HBV, or HCV infections, or have a history of cancer.You have a past of seizures or epilepsy.You have a severe mental health condition such as depression, schizophrenia, bipolar disorder, or substance abuse issues (e.g. heavy alcohol or cigarette use).You have asthma that is not under control and has required hospitalization or emergency room visits in the past 3 months, according to what you tell us.You use Nitroglycerin on a daily basis.You are allergic to NAC or lactose.
Research Study Groups:
This trial has the following groups:- Group 1: N-acetylcysteine
- Group 2: Placebo
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger